BTS #49 David Heldreth Jr. on Cannabis Regulations, The Future of Commercial Cannabinoids, Hunter S ThompsonRead Now
In this behind-the-scenes conversation we sit down with David Heldreth Jr. of Panacea Plant Sciences and Ziese Farms, based out of Washington, USA. Our conversation covered a lot of ground including the past, present and potential future of Cannabis and cannabinoid regulations, what people often misunderstand about rules regarding cannabinoids and other chemical constituents in foods, supplements, and cosmetics, how hemp companies should be preparing for the future of FDA, USDA, and DEA crackdowns, why regulations may be a thing to be celebrated rather than dismissed, what Hunter S. Thompson might have to say about the Cannabis industry, and much more!
This conversation was a long time coming, as David and I have been following each other's work and talking via social media for several years. To learn more about David's work, visit:
Stay curious, and take it easy!
BTS #47 Tanja Bagar, PhD on Medical Cannabis in Europe, ECS Fascinations, International CollaborationRead Now
In this behind-the-scenes conversation we are joined by Tanja Bagar, PhD, the founder and CEO of the International Institute for Cannabinoids, a multi-national research and education cooperative based out of Slovenia. Tanja holds a PhD in Biomedical Sciences and has spent the past several years focused on studying and teaching about cannabinoids throughout Europe. Tanja and I have been collaborating for years as co-authors on conference abstracts, book chapters, etc. Tanja was also one of my early students in the early iterations of my workshop series which I still teach today, so it was great to reconnect on the podcast.
Our conversation explored her experience discovering the therapeutic potential of cannabinoids, how Cannabis regulations vary throughout Europe and the effects that has on research collaboration, why she has become fascinated with the endocannabinoid system, clinical outcomes that ICANNA and their collaborators have seen in patients using cannabinoids, her thoughts about the future of Cannabis research, and much more!
You can learn more about ICANNA by visiting https://www.institut-icanna.com/en/index.html
In this behind-the-scenes conversation we join Dedi Meiri PhD, a researcher at the Israel Institute of Technology focused on examining how Cannabis and its chemical constituents may influence cancer and other disease states. His labs have made important discoveries regarding the relevance of "minor" constituents of Cannabis in influencing cancer activity, among many other things. In this 2+ hour conversation we dive deep into Dedi's background, why he finds Cannabis so interesting, what he has learned from his cancer research, methods that his labs have developed for quickly assessing the activity of plant extracts, the future of Cannabis research, and much more!
Learn more about Dedi's lab at Technion at https://dmeiri.net.technion.ac.il/
In this episode we journey beyond Cannabis and the endocannabinoid system into the endocannabinoidome! The endocannabinoidome is a relatively new concept used to describe the vast hundreds of compounds involved in the functioning of endocannabinoids and cannabinoid receptors. Learn about how this concept of the endocannabinoidome was formed, what clinicians think about its discovery, and what we can expect from the future of endocannabinoidome research! Plus hear an often overlooked story about the origin of "the entourage effect" and how the concept has been redefined for popular culture.
Featuring a contribution from Raphael Mechoulam, PhD via email and relevant excerpts from behind-the-scenes episodes:
BTS #5 Ethan Russo, MD
BTS #31 The Doctors Knox
BTS #35 Vincenzo Di Marzo, PhD
Stay curious, and take it easy!
In this behind-the-scenes episode we join renowned endocannabinoid researcher Dr. Vincenzo Di Marzo, who has been studying endocannabinoids since their discovery in the late 1980s and 1990s. Dr. Di Marzo, along with his colleagues, originally proposed the concept of the endocannabinoid system, the entourage effect, and the endocannabinoidome. Currently Dr. Di Marzo is working on studying the relationships between endocannabinoids and the gut microbiome to better understand how cannabinoids may affect health through the gut. In our conversation we discuss Dr. Di Marzo’s fascination with endocannabinoids, how he conceptualizes the endocannabinoidome, common misunderstandings about endocannabinoids, how the concept of the “entourage effect” has evolved away from its original intended meaning, where the future of Cannabis research may be heading, and much more.
This was a career highlight of mine to be able to talk to Vincenzo and I am honored to share this conversation with you. Enjoy!
In this behind-the-scenes interview we sit down with Sher Ali Butt, the co-founder of CB Therapeutics, a company focused on biosynthesizing cannabinoids and psychedelics using fermentation. We talk about the science behind biosynthetic technology, why they have chosen to focus on psychedelics and cannabinoids, how biosynthesis compares to chemical synthesis techniques for producing compounds, why isolated compounds and complex herbal mixtures both have a place in healthcare, and much more!
Learn more about CB Therapeutics at www.cbthera.com